The expansion of MPOX vaccination
By Lee, Jeong-Hwan | translator Kim, Jung-Ju
23.05.02 17:12:09
°¡³ª´Ù¶ó
0
Agency for Disease Control and Prevention "Spontaneous infection persists, but there is no risk of a pandemic"
Targets for vaccination prior to exposure, current medical staff ¡æ additional plan for 'high risk of infection'
As the number of MPOX cumulative confirmed cases in Korea increased to 49, concerns about community infection grew, and domestic quarantine authorities decided to expand the target of third-generation MPOX vaccine to 'high-risk subjects of infection', drawing attention. Currently, the quarantine authorities are implementing the MPOX 3rd generation vaccine by dividing it into 'pre-exposure vaccination' for medical staff and 'post-exposure vaccination' for contacts. The plan is to add people at high risk of infection among the general public.
The high-risk target for infection is estimated to be 17 million adult
Lee, Jeong-Hwan(junghwanss@dailypharm.com)
If you want to see the full article, please JOIN US (click)